Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Valneva, S&T, Raiffeisen Bank International (05/08/2021)

08.08.2021

Valneva: Valneva SE, an Austrian/French specialty vaccine company, announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553. The trial, involving 4,115 adults, aged 18 years and above, across 44 sites in the U.S., met its primary endpoint inducing protective CHIKV neutralizing antibody titers in 98.5% of participants 28 days after receiving a single shot (264 of 268 subjects from the per-protocol subgroup tested for immunogenicity, 95%CI: 96.2-99.6). The seroprotection rate result of 98.5% exceeded the 70% threshold (for non-acceptance) agreed with the FDA. Juan Carlos Jaramillo, Chief Medical Officer of Valneva commented, “We are delighted with these Phase 3 results confirming the compelling profile of our vaccine candidate across all age groups. These first-ever Phase 3 trial results for a chikungunya vaccine mean that we are a step closer to addressing this major, growing and unmet public health threat. I would like to thank everyone who participated in the trial and who continued to advance the trial during the pandemic. We will continue to work with regulators to bring VLA1553 to market as soon as possible.”
Valneva: weekly performance: -1.32%

S&T: The technology group S&T closes the first half of 2021 with a solid result: revenue rose by 11.5% compared to the previous year to Euro 600.6 mn (PY: Euro 538.7 mn), and EBITDA increased by 12.2% to Euro 58.3 mn (PY: Euro 52.0 million). Despite the chip crisis, the gross margin of 38.8% is almost at the previous year’s level. A sharp increase in the backlog to Euro 1,137 mn as of June 30, 2021, after Euro 927 mn as of December 31, 2020, is particularly encouraging for the S&T Group. Hannes Niederhauser, CEO: “The growth in revenue and the rapidly increasing order intake in the first half year are a good basis for achieving the planned growth of 12% in 2021. The current chip crisis detracts from these good prospects somewhat, since it is delaying deliveries and hindering even stronger growth, which would certainly be possible given the very good order situation. Despite that we can confirm our targets for 2021, namely revenue of at least Euro 1,400 mn with EBITDA at Euro 140 mn. We also reaffirm our medium-term target for 2023 of Euro 2 bn in revenues with EBITDA of at least Euro 220 mn.”
S&T: weekly performance: -2.53%

Raiffeisen Bank International: Raiffeisen Bank International AG (RBI) announced that its Serbian subsidiary Raiffeisen banka a.d. has signed an agreement to acquire 100 per cent of the shares of Crédit Agricole Srbija from Crédit Agricole S.A. Successful closing of the transaction is subject to inter alia obtaining regulatory approvals. The acquisition of Crédit Agricole Srbija is expected to have an impact on RBI’s CET1 ratio of approximately 16 basis points. The final impact is dependent on completion accounts at closing, which is expected by the end of the first quarter of 2022. “Serbia is a very interesting market for us and offers an attractive growth potential. Crédit Agricole Srbija is an excellent strategic fit to our bank in Serbia and the acquisition will support our growth ambition in the market,” said Johann Strobl, CEO of RBI. Crédit Agricole Srbija serves around 356,000 customers. The bank has a leading position in agricultural-business financing (over 20 per cent market share) and thus complements the business profile of Raiffeisen banka a.d. very well. At the end of the second quarter of 2021, Crédit Agricole Srbija had total assets of Euro 1.3 bn, while Raiffeisen banka a.d. reported total assets of Euro 3.4 bn.
RBI: weekly performance: 3.41%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (05/08/2021)


Partners









latest 21st Austria

21st Austria weekly - Valneva, S&T, Raiffeisen Bank International (05/08/2021)


08.08.2021, 3734 Zeichen



Valneva: Valneva SE, an Austrian/French specialty vaccine company, announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553. The trial, involving 4,115 adults, aged 18 years and above, across 44 sites in the U.S., met its primary endpoint inducing protective CHIKV neutralizing antibody titers in 98.5% of participants 28 days after receiving a single shot (264 of 268 subjects from the per-protocol subgroup tested for immunogenicity, 95%CI: 96.2-99.6). The seroprotection rate result of 98.5% exceeded the 70% threshold (for non-acceptance) agreed with the FDA. Juan Carlos Jaramillo, Chief Medical Officer of Valneva commented, “We are delighted with these Phase 3 results confirming the compelling profile of our vaccine candidate across all age groups. These first-ever Phase 3 trial results for a chikungunya vaccine mean that we are a step closer to addressing this major, growing and unmet public health threat. I would like to thank everyone who participated in the trial and who continued to advance the trial during the pandemic. We will continue to work with regulators to bring VLA1553 to market as soon as possible.”
Valneva: weekly performance: -1.32%

S&T: The technology group S&T closes the first half of 2021 with a solid result: revenue rose by 11.5% compared to the previous year to Euro 600.6 mn (PY: Euro 538.7 mn), and EBITDA increased by 12.2% to Euro 58.3 mn (PY: Euro 52.0 million). Despite the chip crisis, the gross margin of 38.8% is almost at the previous year’s level. A sharp increase in the backlog to Euro 1,137 mn as of June 30, 2021, after Euro 927 mn as of December 31, 2020, is particularly encouraging for the S&T Group. Hannes Niederhauser, CEO: “The growth in revenue and the rapidly increasing order intake in the first half year are a good basis for achieving the planned growth of 12% in 2021. The current chip crisis detracts from these good prospects somewhat, since it is delaying deliveries and hindering even stronger growth, which would certainly be possible given the very good order situation. Despite that we can confirm our targets for 2021, namely revenue of at least Euro 1,400 mn with EBITDA at Euro 140 mn. We also reaffirm our medium-term target for 2023 of Euro 2 bn in revenues with EBITDA of at least Euro 220 mn.”
S&T: weekly performance: -2.53%

Raiffeisen Bank International: Raiffeisen Bank International AG (RBI) announced that its Serbian subsidiary Raiffeisen banka a.d. has signed an agreement to acquire 100 per cent of the shares of Crédit Agricole Srbija from Crédit Agricole S.A. Successful closing of the transaction is subject to inter alia obtaining regulatory approvals. The acquisition of Crédit Agricole Srbija is expected to have an impact on RBI’s CET1 ratio of approximately 16 basis points. The final impact is dependent on completion accounts at closing, which is expected by the end of the first quarter of 2022. “Serbia is a very interesting market for us and offers an attractive growth potential. Crédit Agricole Srbija is an excellent strategic fit to our bank in Serbia and the acquisition will support our growth ambition in the market,” said Johann Strobl, CEO of RBI. Crédit Agricole Srbija serves around 356,000 customers. The bank has a leading position in agricultural-business financing (over 20 per cent market share) and thus complements the business profile of Raiffeisen banka a.d. very well. At the end of the second quarter of 2021, Crédit Agricole Srbija had total assets of Euro 1.3 bn, while Raiffeisen banka a.d. reported total assets of Euro 3.4 bn.
RBI: weekly performance: 3.41%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (05/08/2021)



BSN Podcasts
Der Podcast für junge Anleger jeden Alters

SportWoche Podcast S1/08: Plausch mit Sofia Polcanova über Liu Jia, Habesohn / Gardos, John McEnroe und Harry Potter




 

Bildnachweis

Aktien auf dem Radar:Strabag, EVN, CA Immo, Kapsch TrafficCom, Polytec Group, Flughafen Wien, DO&CO, Rosgix, ATX Prime, ATX TR, VIG, voestalpine, Wienerberger, Bawag, Lenzing, Palfinger, ATX, AMS, Marinomed Biotech, Mayr-Melnhof, Uniqa, Oberbank AG Stamm, Immofinanz, S Immo, Airbus Group, Siemens Healthineers, Deutsche Telekom, Münchener Rück, HeidelbergCement, adidas, Fresenius.


Random Partner

Captrace
Captrace ist ein führender Anbieter von Informationssystemen im Bereich Investor Relations. Mit seinem System C◆Tace ermöglicht das Unternehmen dem Emittent größtmögliche Transparenz über seine Investorenstruktur zu erhalten. Durch den Service der Aktionärsidentifikation können Emittenten die Daten ihrer Investoren einfach und zuverlässig über das System C◆Trace von den Banken/Intermediären abfragen.

>> Besuchen Sie 61 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten